Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
Agency: National Institutes of Health
- 93.395 -- Cancer Treatment Research
- 93.394 -- Cancer Detection and Diagnosis Research
Forecasted opportunityLast Updated: May 13, 2026
Important dates
- Forecasted post date: June 15, 2026
- Forecasted application due date: October 5, 2026
- Forecasted award date: July 1, 2027
- Forecasted project start date: July 1, 2027
- Fiscal Year: 2027
Award details
- Expected project funding: Not specified
- Expected awards: Not specified
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:PAR-26-129
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: March 11, 2026
- Archive date: Not specified
- Version: 1
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support research projects that employ state-of-the-art cancer biology approaches and preclinical model systems to investigate the biological effects of radiation emitted by radionuclides used in radiopharmaceutical therapy (RPT). The focus of this initiative is to advance mechanistic understanding of how different forms of radionuclide-emitted radiation affect normal tissues, tumor cells, and the tumor microenvironment, and how these effects can be leveraged to improve therapeutic outcomes. This NOFO will support the Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) program. The overarching goal of STRIPE is to stimulate multidisciplinary research that integrates cancer biology, radiation biology, radiochemistry, imaging, dosimetry, and preclinical modeling. Funded projects are expected to generate fundamental biological insights that can serve as the foundation for the development of new targeting strategies, optimized treatment regimens, and innovative combination approaches for RPT, ultimately leading to more effective and precise anticancer therapies.
This NOFO consolidates prior exploratory/developmental and research project funding mechanisms to streamline the application process and sustain momentum in this critical research area. The applicants have the option of submitting either for exploratory/developmental research projects with a project period of up to 2 years or for research projects with a project period of 4 to 5 years. Collectively, the STRIPE program is intended to broaden the scientific base of RPT research, lower barriers to entry for cancer biology investigators, and accelerate the generation of reproducible, mechanistically informed data that will enable more effective and personalized use of radiopharmaceutical therapies in cancer care.
Eligibility
Government
- State governments
- Public and Indian housing authorities
- City or township governments
- Special district governments
- County governments
- Federally recognized Native American tribal governments
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
Business
- For-profit organizations other than small businesses
- Small businesses
Miscellaneous
- Other
Education
- Public and state institutions of higher education
- Independent school districts
- Private institutions of higher education
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: Email: STRIPE-ProgramContact@mail.nih.gov
Email: STRIPE-ProgramContact@mail.nih.gov
Link to additional information
No additional information is available
